骨水泥品牌与混合顺序决定高剂量万古霉素从PMMA间隔物中的洗脱
结果显示品牌和混合顺序显著影响洗脱,Palacos MV单体优先累计洗脱最高,Simplex P聚合物优先初始洗脱最高,所有配方均保持杀菌活性。
要点
- Palacos MV单体优先混合的28天累计洗脱量最高(2,897±64 µg/mL)。
- Simplex P聚合物优先混合的1小时初始洗脱量最高(415±33 µg/mL)。
- 混合顺序未显著影响PMMA孔隙率,所有配方万古霉素均保持杀菌活性。
核心结论
- 骨水泥品牌和混合顺序显著影响高剂量万古霉素从PMMA中的洗脱,Palacos MV单体优先累计洗脱最高,Simplex P聚合物优先初始释放最高。
主要发现
- Palacos MV单体优先混合的28天累计洗脱量为2,897±64 µg/mL,比Simplex P单体优先混合高120%。
- Palacos MV单体优先混合的洗脱量比高粘度Palacos R单体优先混合高57%。
- Simplex P聚合物优先混合第1小时洗脱量为415±33 µg/mL,28天累计洗脱量比其单体优先混合高52%。
- 预混庆大霉素仅增加高粘度配方的万古霉素洗脱。
- 所有配方中万古霉素均保持对甲氧西林敏感金黄色葡萄球菌的杀菌活性,孔隙率无显著差异。
关键数值与推荐
- Palacos MV单体优先混合28天累计洗脱2,897±64 µg/mL,较Simplex P单体优先混合高120%。
- Simplex P聚合物优先混合第1小时洗脱415±33 µg/mL,28天累计洗脱较其单体优先混合高52%。
- Palacos MV单体优先混合洗脱量较高粘度Palacos R单体优先混合高57%。
临床怎么用
- 在翻修关节置换中制备高剂量间隔物时,临床医生应考虑PMMA品牌、粘度和混合顺序以优化万古霉素释放。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-dose vancomycin is routinely mixed into polymethylmethacrylate (PMMA) spacers for chronic periprosthetic joint infection (PJI). The precise manner by which to maximize elution remains unknown, and the impact of PMMA-antibiotic mixing sequences remains unexplored. METHODS: Sixty PMMA discs (5 formulations consisting of 2 PMMA brands, 2 viscosities, presence or absence of premixed gentamicin) were mixed with 4 g of vancomycin using either a polymer-first or monomer-first sequence. Vancomycin elution was quantified over 28 days, antimicrobial activity against methicillin-sensitive Staphylococcus aureus was tested, and micro-computed tomography scans were performed to assess porosity. Elution amounts were compared with Holm-corrected t tests and are reported as the mean ± standard error. RESULTS: Vancomycin retained bactericidal activity across all formulations. Monomer-first mixing of Palacos MV (medium-viscosity) yielded the greatest cumulative elution (2,897 ± 64 µg/mL), 120% greater than monomer-first mixing of Simplex P. A monomer-first sequence increased vancomycin elution from medium-viscosity Palacos MV by 57% compared with high-viscosity Palacos R. Polymer-first mixing of Simplex P yielded the greatest immediate elution over the first hour (415 ± 33 µg/mL), as well as a 52% greater cumulative elution amount over 28 days versus its monomer-first sequence. Premixed gentamicin only increased vancomycin elution for high-viscosity formulations. No significant differences were seen in porosity. CONCLUSIONS: The cement brand and mixing sequence significantly influenced elution of high-dose vancomycin from PMMA. Palacos MV mixed monomer-first produced the greatest cumulative antibiotic delivery, whereas polymer-first Simplex P maximized initial release. The mixing methods did not deleteriously affect PMMA integrity or antimicrobial activity. CLINICAL RELEVANCE: Clinicians should consider their choice of PMMA brand, viscosity, and mixing sequence when preparing high-dose spacers in revision arthroplasty for PJI. Maximizing cumulative elution may be a clinically favorable strategy to improve PJI eradication.
引用
- Hammad M, Chao CA, Bostrom MP, et al. Cement Brand and Mixing Sequence Determine Vancomycin Elution from High-Dose PMMA Spacers: An in Vitro Comparative Study. J Bone Joint Surg Am. 2026. PMID: 42743313. doi:10.2106/JBJS.25.00745
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。